Medical Device Industry Executive Joins Teleflex as Executive Vice President and CFOLIMERICK, Pa., Jan 11, 2010 (BUSINESS WIRE) -- Teleflex Incorporated (NYSE:TFX) has announced the appointment of
Richard (Randy) Meier as executive vice president and chief financial
officer, effective the close of business today. Mr. Meier was previously
president and chief operating officer of Advanced Medical Optics, Inc.,
a publicly-traded $1.2 billion global ophthalmic medical device company.
"Randy brings a depth of experience to the chief financial officer role,
with more than 10 years of financial and operational leadership in
medical device and pharmaceutical companies," said Jeffrey P. Black,
Teleflex chairman and chief executive officer. "His proven track record
leading high performance, fast-growth organizations is a great addition
to our team as we execute on our strategic initiatives."
Added Black, "Randy has demonstrated strong financial acumen and a
commitment to maintaining solid financial fundamentals and operational
effectiveness programs while building organizations that can deliver
consistent revenue growth through targeted acquisitions and organic
growth initiatives. We look forward to his future contributions at
Teleflex."
Mr. Meier succeeds Kevin K. Gordon who, as previously announced, is
leaving Teleflex this month after 13 years with the company.
Mr. Meier is currently a member of the board of directors of BioMarin
Pharmaceuticals, Inc. and Staar Surgical Co. He was an executive with
Advanced Medical Optics, Inc. (NYSE:EYE) from 2002 until the company was
acquired in 2009. He served as executive vice president and chief
financial officer of Valeant Pharmaceuticals, Inc. (NYSE:VRX) from
1999-2002.
About Teleflex Incorporated
Teleflex is a diversified global company with a significant presence in
medical technology and niche businesses serving aerospace and commercial
markets. Teleflex Medical, the company's largest business segment,
designs, manufactures and distributes medical devices for critical care
and surgical applications serving customers in more than 140 countries.
The company is focused on medical device technology that enables
healthcare providers to improve outcomes, reduce infections and improve
patient and provider safety. Additional information about Teleflex can
be obtained from the company's website at www.teleflex.com.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze, 610-948-2836
Vice President Investor Relations